← Leaderboards
Raymond P Perez
Dartmouth College
$3,553,952
Attributed
$3,553,952
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $549.6K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,553,952 · 7
By mechanism
P30$1,700,848 · 3
R21$1,203,484 · 3
K24$649,620 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- Anna N. A. Tosteson$20,584,945
- Marie Anne Bakitas$7,938,755
- Jennifer A Miglionico$0
- Mark T Hegel$1,638,849
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBaseClinical TrialsResearch PersonnelProtocols DocumentationCancer CenterMonitorReportingSafetyClinical Trials Data Monitoring CommitteesCancer Center Support GrantPrincipal InvestigatorAdverse EventEnrollmentPharmaceutical PreparationsMelanomaNeoplasm /Cancer ChemotherapyPhase Iii Clinical TrialsEnsureHuman SubjectDatabasesFundingHuman Therapy EvaluationAnticancer Research
Grant awards (29)
DATA AND SAFETY MONITORING$124,348
P30 · FY2014 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$124,348
P30 · FY2014 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$113,018
P30 · FY2013 · CA · contact PI
DATA AND SAFETY MONITORING$25,659
P30 · FY2013 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$120,685
P30 · FY2012 · CA · contact PI
DATA AND SAFETY MONITORING$27,310
P30 · FY2012 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$119,702
P30 · FY2011 · CA · contact PI
DATA AND SAFETY MONITORING$27,181
P30 · FY2011 · CA · contact PI
Inhibition of S14 by Conjugated Linoleic Acid in Advanced Solid Tumor Patients$208,560
R21 · FY2010 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$136,317
P30 · FY2010 · CA · contact PI
SPRY2 predicts survival post-chemotherapy in advanced ovarian cancer.$87,339
R21 · FY2010 · CA · contact PI
SPRY2 predicts survival post-chemotherapy in advanced ovarian cancer.$86,461
R21 · FY2010 · CA · contact PI
DATA AND SAFETY MONITORING$30,954
P30 · FY2010 · CA · contact PI
Inhibition of S14 by Conjugated Linoleic Acid in Advanced Solid Tumor Patients$208,560
R21 · FY2009 · CA · contact PI
SPRY2 predicts survival post-chemotherapy in advanced ovarian cancer.$173,974
R21 · FY2009 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$128,026
P30 · FY2009 · CA · contact PI
DATA AND SAFETY MONITORING$29,070
P30 · FY2009 · CA · contact PI
Clinical Research$217,912
P30 · FY2008 · CA · contact PI
Clinical Research$205,362
P30 · FY2007 · CA · contact PI
Clinical Research$93,001
P30 · FY2006 · CA · contact PI
Clinical Research$90,293
P30 · FY2005 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY$129,924
K24 · FY2004 · CA
Clinical Research$87,662
P30 · FY2004 · CA
Atorvastatin, a prenylation inhibitor in acute leukemia.$213,202
R21 · FY2003 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY$129,924
K24 · FY2003 · CA
Atorvastatin, a prenylation inhibitor in acute leukemia.$225,388
R21 · FY2002 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY$129,924
K24 · FY2002 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY$129,924
K24 · FY2001 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY$129,924
K24 · FY2000 · CA